BeOne Medicines Ltd.（ONC）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · ONC · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$5.34B	$3.81B	$2.46B	$1.42B	$1.18B
Cost of Revenue	$0.67B	$0.59B	$0.38B	$0.29B	$0.16B
Gross Profit	$4.67B	$3.22B	$2.08B	$1.13B	$1.01B
Gross Margin %(computed)	87.49%	84.41%	84.55%	79.77%	85.98%
Operating Expenses
R&D Expenses	$2.15B	$1.95B	$1.78B	$1.64B	$1.46B
G&A Expenses	$0.00B	$0.00B	$0.00B	$0.00B	$0.00B
Total Operating Expenses	$4.23B	$3.78B	$3.29B	$2.92B	$2.45B
Operating Income	$0.45B	($0.57B)	($1.21B)	($1.79B)	($1.44B)
Operating Margin %(computed)	8.37%	-14.91%	-49.12%	-126.40%	-122.31%
Interest Income	$0.07B	$0.05B	$0.07B	$0.05B	$0.02B
Interest Expense	$0.06B	$0.00B	$0.00B	$0.00B	$0.00B
Income Before Tax	$0.42B	($0.53B)	($0.83B)	($1.96B)	($1.44B)
Income Tax Expense	$0.13B	$0.11B	$0.06B	$0.04B	$0.02B
Net Income	$0.29B	($0.64B)	($0.88B)	($2.00B)	($1.46B)
Net Margin %(computed)	5.37%	-16.92%	-35.86%	-141.52%	-123.93%
Per Share & EBITDA
EPS (Basic)	$33.80	$-6.12	$-8.45	$-19.37	$-15.21
Wtd Avg Shares	0.11B	0.11B	0.10B	0.10B	0.09B
EBITDA	$0.62B	($0.40B)	($1.12B)	($1.72B)	($1.39B)
EBITDA Margin %(computed)	11.54%	-10.40%	-45.55%	-121.71%	-118.36%